STOCK TITAN

Bausch & Lomb (NYSE: BLCO) EVP awarded 35,046 restricted share units

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Hashad Yehia reported acquisition or exercise transactions in this Form 4 filing.

Bausch & Lomb Corp executive Yehia Hashad, EVP of R&D and CMO, received a grant of 35,046 restricted share units (RSUs) on common shares at a price of $0.00 per share. After this equity award, his directly held common shares total 198,906.

The RSUs were granted under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan and are scheduled to vest in three equal annual installments on each of the first three anniversaries of the grant date, subject to continued service and plan terms. Vested RSUs will be settled in common shares of Bausch & Lomb.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hashad Yehia

(Last) (First) (Middle)
C/O BAUSCH + LOMB CORPORATION
520 APPLEWOOD CRESCENT

(Street)
VAUGHAN A6 L4K4B4

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Bausch & Lomb Corp [ BLCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP of R&D and CMO
3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares, No Par Value 02/25/2026 A 35,046(1) A $0 198,906 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.
/s/ Debra E. Levin, attorney-in-fact 02/27/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider equity award did Bausch & Lomb (BLCO) report for Yehia Hashad?

Bausch & Lomb reported that EVP of R&D and CMO Yehia Hashad received a grant of 35,046 restricted share units. These RSUs are part of his equity compensation and will convert into common shares over time if vesting conditions are satisfied.

How do the new RSUs granted to Yehia Hashad at BLCO vest?

The 35,046 restricted share units granted to Yehia Hashad vest in three equal installments. One-third of the RSUs vests on each of the first three anniversaries of the grant date, assuming he continues to serve and meets applicable plan and award conditions.

What is Yehia Hashad’s total Bausch & Lomb share ownership after this Form 4?

Following the reported RSU award, Yehia Hashad directly holds 198,906 common shares of Bausch & Lomb. This figure reflects the impact of the new grant as reported, combining previously held shares with the additional equity awarded in this transaction.

Did Yehia Hashad pay for the Bausch & Lomb RSUs reported on this Form 4?

The RSU grant to Yehia Hashad carried a reported transaction price of $0.00 per share. This indicates a compensatory equity award rather than an open-market purchase, consistent with grants made under the company’s 2022 Omnibus Incentive Plan.

Under which plan were Yehia Hashad’s new BLCO restricted share units granted?

The 35,046 RSUs reported for Yehia Hashad were granted under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vesting and settlement are governed by this plan and the specific award agreement’s terms and conditions.

How are Yehia Hashad’s Bausch & Lomb RSUs settled when they vest?

Once vested, Yehia Hashad’s restricted share units are settled in Bausch & Lomb common shares with no par value. This means each vested RSU converts into common stock, increasing his actual share ownership, subject to the plan and applicable award agreement.
Bausch + Lomb Corporation

NYSE:BLCO

BLCO Rankings

BLCO Latest News

BLCO Latest SEC Filings

BLCO Stock Data

6.55B
38.66M
Medical Instruments & Supplies
Ophthalmic Goods
Link
Canada
VAUGHAN